NeoStem Inc. (NYSEMKT:NBS): On the Leading Edge of the Advancement of Cell Therapy

By Craig Keolanui  Is stem cell therapy going to be to the biotechnology industry what Tesla Motors is to the automotive industry? Stem cell therapy has waited at the sidelines while investors pump billions of dollars into the pharmaceutical industry in the hopes of getting drugs approved by the FDA to alleviate symptoms. Stem cell therapy […]